By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Medivir AB 

Lunastigen 7

Huddinge    141 44  Sweden
Phone: 46-8-608-3100 Fax: 46-8-608-3199




GlaxoSmithKline (North Carolina) 

Peptimmune, Inc.  Development agreement for inhibitors of Cathepsin S for autoimmune and allergic diseases.

Company News
Medivir (MVRBF) Announces The First Cancer Project Derived From Its In-House Nucleotide Platform 6/30/2015 12:07:52 PM
Medivir (MVRBF) Reorganizes and Ditches Neuropathic Pain R&D 6/16/2015 5:57:24 AM
Medivir AB (MVRBF)’s Board Of Directors Has Resolved To Repurchase Own Shares 5/6/2015 9:58:59 AM
Medivir AB (MVRBF): Positive Preclinical Antiviral And Safety Profile Of MIV-802 Supports Continued Development 4/23/2015 8:36:05 AM
Medivir AB (MVRBF): Data From OPTIMIST Trials Show SVR12 Rates Of 97 Percent In HCV Patients Without Cirrhosis And 84 Percent In HCV Patients With Cirrhosis 4/23/2015 6:16:02 AM
Medivir AB (MVRBF) And Cancer Research Technology Collaborate To Develop New Class Of Cancer Drugs 4/13/2015 11:40:26 AM
Medivir AB (MVRBF): New simeprevir Data Will Be Presented At The International Liver Congress 2015 Of The European Association For The Study Of The Liver (EASL) 4/8/2015 9:55:50 AM
Medivir AB (MVRBF): Annual Report 2014 4/7/2015 11:06:35 AM
Medivir AB (MVRBF): New Data On Simeprevir Presented At The Conference Of The Asian Pacific Association For The Study Of The Liver 3/16/2015 12:54:28 PM
Medivir AB (MVRBF) Capital Markets Meeting On 26 March 2015 3/12/2015 12:50:33 PM